Form 8-K - Current report:
SEC Accession No. 0001140361-21-014148
Filing Date
2021-04-23
Accepted
2021-04-23 17:20:08
Documents
2
Period of Report
2021-04-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10023524_8k.htm 8-K 20931
2 EXHIBIT 16.1 brhc10023524_ex16-1.htm EX-16.1 1648
  Complete submission text file 0001140361-21-014148.txt   24032
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 21850713
SIC: 2834 Pharmaceutical Preparations